Quantiphi Collaborates with Cerevel Therapeutics to Harness the Power of Google Cloud’s AI in Clinical Workflow Management

Quantiphi, an AI-first digital engineering company,announced that it has entered into a collaboration with Cerevel Therapeutics  to harness the power of Google Cloud’s Artificial Intelligence (AI) in clinical workflow management, with the goal of improving Cerevel’s capabilities to deliver neuroscience solutions to patients as quickly as possible.

With Quantiphi’s end-to-end Doc AI solution built on Google Cloud, Cerevel aims to improve the way medical information is processed with greater speed and accuracy. This automated workflow will enable the Company to review, extract and store information from clinical site monitoring reports to flag the review priority.  Ultimately, this system reduces manual, time-consuming tasks and allows for complete coverage in a rigorous, consistent and timely manner.

Recommended AI News: Talkwalker Reveals How Brands Can Leverage Consumer Intelligence to ‘Shape Tomorrow’ for Growth

With Doc AI, Cerevel can now process information from trip reports across four templates. The custom-built user interface will allow Cerevel to visualize the status of each action item and decide the best course of action. This system not only reduces manual effort but also fast-tracks the process and clears backlogs.

“Cerevel is committed to executional excellence, and this collaboration and AI solution has given our teams greater insights into reporting across clinical workflows, allowing us to better manage our clinical trials with a focus on quality and compliance. Our teams are excited to add this tool to their arsenal and have already started evaluating additional AI capabilities to further support our mission to push boundaries, develop solutions and transform lives.”

Laura Whitmore, Senior Director, Clinical Operations Oversight, Cerevel Therapeutics

“Google Cloud has proven to be a powerful platform for Cerevel as we unravel the mysteries of the brain to treat neuroscience diseases. We have combined Google Cloud’s technology, Quantiphi’s technical expertise in Artificial Intelligence, and Cerevel’s deep domain expertise to accelerate our Cloud and Digital Transformation strategy.”

Doug Barta, Chief Information Officer, Cerevel Therapeutics

“At Google Cloud we aim to provide best in class infrastructure to organize the world’s data. Across biotechnology firms we have seen this pursuit unlock data sets that were previously unavailable to the scientific teams and investigators. With the application of AI and machine learning technologies to documents, physician notes, electronic medical records and other datasets, we believe companies like Cerevel will be one step closer to a more effective clinical trial environment and gain greater insight into patient care.”

Recommended AI News: Credera Attains AWS Well-Architected Partner Program Membership

Shweta Maniar, Director of Life Sciences Industry Solutions, Google Cloud

“We are delighted to partner with Cerevel and transform the way medical records are processed today. This solution is a step forward towards increasing the accuracy and quality of medical record analysis, reducing the burden on healthcare practitioners and enabling them to precisely target those that need additional attention. This partnership will unlock the transformative power of cloud, data and AI technologies to solve the most pressing problems in the field of neuroscience.”

Recommended AI News: Qrvey Ranked Among Top Embedded Business Intelligence Vendors by Dresner Advisory Services

[To share your insights with us, please write to sghosh@martechseries.com]